A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial to Determine the Efficacy of Oral Zafirlukast (ACCOLATE) When Administered According to Current Labeling Instructions or Simplified Dosing Instructions in Subjects With Asthma Receiving Inhaledb2-agonist Alone or Inhaled b2-agonist in Combination With Inhaled Corticosteroids (ICS) (9188IL0155)

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].